Fig. 1From: Histologic tumor type as a determinant of survival in hormone receptor-positive, HER2-negative, pT1-3 invasive ductal and lobular breast cancerKaplan–Meier curves for DFS of patients with HR + , HER2-, pT1-3 IDC or ILC. DFS as fraction of total number of patients with IDC (n = 984) or ILC (n = 144) and pN0, log rank test not significant (left) and of patients with IDC (n = 551) or ILC (n = 107) and pN ≥ 1, log rank test p = 0.02 (right)Back to article page